Point72 Hong Kong’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-22
| Closed | -$4K | – | 226 |
|
2022
Q3 | $4K | Sell |
22
-213
| -91% | -$38.7K | ﹤0.01% | 1274 |
|
2022
Q2 | $50K | Buy |
+235
| New | +$50K | ﹤0.01% | 928 |
|
2021
Q4 | – | Sell |
-224
| Closed | -$109K | – | 1373 |
|
2021
Q3 | $109K | Buy |
+224
| New | +$109K | ﹤0.01% | 716 |
|
2021
Q2 | – | Sell |
-33
| Closed | -$23K | – | 1386 |
|
2021
Q1 | $23K | Buy |
+33
| New | +$23K | ﹤0.01% | 929 |
|
2020
Q4 | – | Sell |
-127
| Closed | -$88K | – | 1278 |
|
2020
Q3 | $88K | Buy |
+127
| New | +$88K | 0.01% | 579 |
|
2020
Q1 | – | Sell |
-96
| Closed | -$22K | – | 980 |
|
2019
Q4 | $22K | Buy |
96
+51
| +113% | +$11.7K | 0.01% | 853 |
|
2019
Q3 | $5K | Buy |
+45
| New | +$5K | ﹤0.01% | 806 |
|
2018
Q4 | – | Sell |
-28
| Closed | -$3K | – | 904 |
|
2018
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 732 |
|
2018
Q2 | $4K | Sell |
28
-359
| -93% | -$51.3K | ﹤0.01% | 717 |
|
2018
Q1 | $63K | Buy |
+387
| New | +$63K | 0.03% | 410 |
|